Hodgkin's lymphoma

Standing Up To The Test Of Time: Two Cancer Drugs That Could Survive A Hobbled FDA
Forbes
Thu, 12/8/16 - 09:59 am
FDA
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
AbbVie
JNJ
Ibruvica
mantle cell lymphoma
Seattle Genetics drug gets OK for additional cancer therapies in Europe
Bizjournals.com
Wed, 07/6/16 - 11:08 am
Seattle Genetics
Europe
Adcetris
Hodgkin's lymphoma
Bristol-Myers extends lead with new Opdivo indication
BioPharma Dive
Tue, 05/17/16 - 05:20 pm
Bristol-Myers Squibb
Opdivo
Hodgkin's lymphoma
FDA
Bristol Myers Set to Enhance Dominance in Immunotherapies Market
Bidness, ETC
Sat, 04/16/16 - 04:10 pm
Bristol-Myers Squibb
Opdivo
cancer immunotherapy
Hodgkin's lymphoma
Keytruda, Opdivo near new cancer uses where they won't butt heads
Fierce Pharma
Fri, 04/15/16 - 08:39 am
Keytruda
Opdivo
Bristol-Myers Squibb
Merck
Hodgkin's lymphoma
head and neck cancer
U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibb’s Supplemental Biologics License Application for Opdivo® (nivolumab) for the Treatment of Classical Hodgkin Lymphoma Patients
Yahoo
Thu, 04/14/16 - 09:13 am
Bristol-Myers Squibb
Opdivo
Hodgkin's lymphoma
FDA
Seattle Genetics drug wins FDA approval, could boost biotech's revenue
Bizjournals.com
Tue, 08/18/15 - 09:23 pm
FDA
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/7/14 - 10:19 am
Merck
Keytruda
Hodgkin's lymphoma
Opdivo (nivolumab) Demonstrates High Overall Response Rate of 87% for Treatment of Relapsed or Refractory Hodgkin Lymphoma
Yahoo/BusinessWire
Sun, 12/7/14 - 10:11 am
Opdivo
Hodgkin's lymphoma
Bristol-Myers Squibb
Seattle Genetics Makes Case for Expanded Use of Adcetris as Lymphoma Maintenance Therapy
The Street
Sun, 12/7/14 - 10:09 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
Yahoo/BusinessWire
Sat, 12/6/14 - 11:15 am
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win
TheStreet.com
Mon, 09/29/14 - 10:16 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Safety Concern Halts Study of Seattle Genetics' Lymphoma Drug
TheStreet.com
Tue, 06/25/13 - 12:19 pm
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/2/13 - 11:43 am
Seattle Genetics
Adcetris
T-cell lymphoma
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
Seattle Genetics updates survival data from Adcetris trial for Hodkin lymphoma
Yahoo/Fly on the Wall
Thu, 06/14/12 - 11:14 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
It's Fashionably Late, but This Biotech's Party Is Just Starting
Motley Fool
Sat, 04/14/12 - 12:27 pm
Seattle Genetics
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Seattle Genetics: A Cancer Niche Too Small
TheStreet.com
Mon, 03/5/12 - 11:11 am
Seattle Genetics
Adcetris
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
Seattle Genetics: Boxed Warning Is A Non-Event
Seeking Alpha
Sun, 01/22/12 - 12:32 pm
Seattle Genetics
progressive multifocal leukoencephalopathy
PML
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Seattle Genetics Lymphoma Drug Gets Boxed Warning on Brain Infection Risk
Bloomberg
Sat, 01/14/12 - 11:25 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
progressive multifocal leukoencephalopathy
PML
Seattle Genetics’ Adcetris Is Well Tolerated in Drug Combination
Bloomberg
Tue, 12/13/11 - 11:48 am
Adcetris
Seattle Genetics
Hodgkin's lymphoma

Pages